Publications

Export 22 results:
Author Title Type [ Year(Asc)]
Filters: Keyword is Positron-Emission Tomography  [Clear All Filters]
2017
Grothe MJ, Villeneuve S, Dyrba M, Bartrés-Faz D, Wirth M.  2017.  Multimodal characterization of older APOE2 carriers reveals selective reduction of amyloid load.. Neurology. 88(6):569-576.
Parent MJ, Zimmer ER, Shin M, Kang MSu, Fonov VS, Mathieu A, Aliaga A, Kostikov A, Carmo SDo, Dea D et al..  2017.  Multimodal Imaging in Rat Model Recapitulates Alzheimer's Disease Biomarkers Abnormalities.. J Neurosci. 37(50):12263-12271.
Ng KPin, Pascoal TA, Mathotaarachchi S, Chung C-O, Benedet AL, Shin M, Kang MSu, Li X, Ba M, Kandiah N et al..  2017.  Neuropsychiatric symptoms predict hypometabolism in preclinical Alzheimer disease.. Neurology. 88(19):1814-1821.
2016
Laforce R, Rosa-Neto P, Soucy J-P, Rabinovici GD, Dubois B, Gauthier S.  2016.  Canadian Consensus Guidelines on Use of Amyloid Imaging in Canada: Update and Future Directions from the Specialized Task Force on Amyloid imaging in Canada.. Can J Neurol Sci. 43(4):503-12.
DuBois JM, Rousset OG, Rowley J, Porras-Betancourt M, Reader AJ, Labbe A, Massarweh G, Soucy J-P, Rosa-Neto P, Kobayashi E.  2016.  Characterization of age/sex and the regional distribution of mGluR5 availability in the healthy human brain measured by high-resolution [(11)C]ABP688 PET.. Eur J Nucl Med Mol Imaging. 43(1):152-62.
Chung JKu, Plitman E, Nakajima S, M Chakravarty M, Caravaggio F, Gerretsen P, Iwata Y, Graff-Guerrero A.  2016.  Cortical Amyloid β Deposition and Current Depressive Symptoms in Alzheimer Disease and Mild Cognitive Impairment.. J Geriatr Psychiatry Neurol. 29(3):149-59.
Richard MAnne, Fouquet JP, Lebel R, Lepage M.  2016.  MRI-Guided Derivation of the Input Function for PET Kinetic Modeling.. PET Clin. 11(2):193-202.
Leh SE, Kälin AM, Schroeder C, Park MTae M, M Chakravarty M, Freund P, Gietl AF, Riese F, Kollias S, Hock C et al..  2016.  Volumetric and shape analysis of the thalamus and striatum in amnestic mild cognitive impairment.. J Alzheimers Dis. 49(1):237-49.
2015
Breitner JCS.  2015.  Comment: Yet another "disconnect" between amyloid and Alzheimer disease? Neurology. 85(8):698.
Villeneuve S, Rabinovici GD, Cohn-Sheehy BI, Madison C, Ayakta N, Ghosh PM, La Joie R, Arthur-Bentil SKate, Vogel JW, Marks SM et al..  2015.  Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation.. Brain. 138(Pt 7):2020-33.
Zimmer ER, Parent MJ, Leuzy A, Aliaga A, Aliaga A, Moquin L, Schirrmacher ES, Soucy J-P, Skelin I, Gratton A et al..  2015.  Imaging in vivo glutamate fluctuations with [(11)C]ABP688: a GLT-1 challenge with ceftriaxone.. J Cereb Blood Flow Metab. 35(7):1169-74.
Chung JKu, Plitman E, Nakajima S, Chow TW, M Chakravarty M, Caravaggio F, Gerretsen P, Brown EE, Iwata Y, Mulsant BH et al..  2015.  Lifetime History of Depression Predicts Increased Amyloid-β Accumulation in Patients with Mild Cognitive Impairment.. J Alzheimers Dis. 45(3):907-19.
Kim D, Kim RGyung, Kim H-S, Kim J-M, Jun SChan, Lee B, Jo HJoon, Neto PR, Lee M-C, Kim H-I.  2015.  Longitudinal changes in resting-state brain activity in a capsular infarct model.. J Cereb Blood Flow Metab. 35(1):11-9.
Hernaus D, Collip D, Kasanova Z, Winz O, Heinzel A, van Amelsvoort T, Shali SM, Booij J, Rong Y, Piel M et al..  2015.  No evidence for attenuated stress-induced extrastriatal dopamine signaling in psychotic disorder.. Transl Psychiatry. 5:e547.
Vafaee MS, Gjedde A, Imamirad N, Vang K, M Chakravarty M, Lerch JP, Cumming P.  2015.  Smoking normalizes cerebral blood flow and oxygen consumption after 12-hour abstention.. J Cereb Blood Flow Metab. 35(4):699-705.
Bernard-Gauthier V, Aliaga A, Aliaga A, Boudjemeline M, Hopewell R, Kostikov A, Rosa-Neto P, Thiel A, Schirrmacher R.  2015.  Syntheses and evaluation of carbon-11- and fluorine-18-radiolabeled pan-tropomyosin receptor kinase (Trk) inhibitors: exploration of the 4-aza-2-oxindole scaffold as Trk PET imaging agents.. ACS Chem Neurosci. 6(2):260-76.
2014
Lataster J, Collip D, Ceccarini J, Hernaus D, Haas D, Booij L, van Os J, Pruessner J, Van Laere K, Myin-Germeys I.  2014.  Familial liability to psychosis is associated with attenuated dopamine stress signaling in ventromedial prefrontal cortex.. Schizophr Bull. 40(1):66-77.
Milella MS, Marengo L, Larcher K, Fotros A, Dagher A, Rosa-Neto P, Benkelfat C, Leyton M.  2014.  Limbic system mGluR5 availability in cocaine dependent subjects: a high-resolution PET [(11)C]ABP688 study.. Neuroimage. 98:195-202.
Zimmer ER, Parent MJ, A Cuello C, Gauthier S, Rosa-Neto P.  2014.  MicroPET imaging and transgenic models: a blueprint for Alzheimer's disease clinical research.. Trends Neurosci. 37(11):629-41.
Kim H-S, Kim D, Kim RGyung, Kim J-M, Chung E, Neto PR, Lee M-C, Kim H-I.  2014.  A rat model of photothrombotic capsular infarct with a marked motor deficit: a behavioral, histologic, and microPET study.. J Cereb Blood Flow Metab. 34(4):683-9.
Zimmer ERigon, Leuzy A, Benedet ALessa, Breitner JCS, Gauthier S, Rosa-Neto P.  2014.  Tracking neuroinflammation in Alzheimer's disease: the role of positron emission tomography imaging.. J Neuroinflammation. 11:120.
Leuzy A, Zimmer ERigon, Heurling K, Rosa-Neto P, Gauthier S.  2014.  Use of amyloid PET across the spectrum of Alzheimer's disease: clinical utility and associated ethical issues.. Amyloid. 21(3):143-8.
  • Douglas Hospital
  • Dobell Pavillion
  • Brain imaging centre